EV Biologics, Inc. (YECO)

OTCMKTS: YECO · Delayed Price · USD
0.800
0.00 (0.00%)
Feb 3, 2023, 10:43 AM EST - Market closed
Market Cap 40.63M
Revenue (ttm) 48.81M
Net Income (ttm) -68.73M
Shares Out 33.58M
EPS (ttm) -28.63
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,000
Open 0.800
Previous Close 0.800
Day's Range 0.800 - 0.800
52-Week Range 0.252 - 2.340
Beta -0.77
Analysts n/a
Price Target n/a
Earnings Date n/a

About YECO

EV Biologics, Inc., a biotechnology company, engages in the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics. It is involved in developing vaccines, therapeutics, and cures based on its proprietary multifunctional EV platform. The company also focuses on developing human mesenchymal and other stem cell, and cell-derived products to market in the cosmetic and biopharmaceutical spaces. The company was formerly known as Yulong Eco-Materials Limited and changed its name to EV Biologics... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2011
Employees 284
Stock Exchange OTCMKTS
Ticker Symbol YECO
Full Company Profile

Financial Performance

In 2017, EV Biologics's revenue was $9.47 million, a decrease of -0.34% compared to the previous year's $9.51 million. Losses were -$551,581, -92.58% less than in 2017.

Financial Statements

News

EV Biologics Updates on Excyte Subsidiary Funding

TAMPA, FL / ACCESSWIRE / January 3, 2023 / EV Biologics Corp, OTC PINK:YECO, today announced that it has now closed $1,000,000 of its $2.5 million initial capitalization goal. One hundred thousand sha...

1 month ago - Accesswire

EV Biologics Initiates PCAOB Audit to Seek Uplift to OTCQX

TAMPA, FL / ACCESSWIRE / November 14, 2022 / EV Biologics Corp, (OTC PINK:YECO), today announced that it is initiating a PCAOB audit for 2021 and 2022 and intends to file an application to list on the...

2 months ago - Accesswire

EV Biologics Launches Excyte with $100 million Valuation

TAMPA, FL / ACCESSWIRE / August 15, 2022 / EV Biologics Corp, OTC Pink: YECO, today announced that it has launched Excyte, Inc., a wholly owned subsidiary, with $100 Million valuation. Excyte has alre...

6 months ago - Accesswire

EV Biologics Signs MSA with LONZA Cell & Gene Therapy

HOUSTON, TX / ACCESSWIRE / May 17, 2022 / EV Biologics Corp, OTC PINK:YECO, today announced that it has signed a Manufacturing Services Agreement (MSA) with Lonza for development of stem/progenitor ce...

9 months ago - Accesswire

EV Biologics Isolates Primary Cells for Nanoparticle Production & Accelerated Cell Line Development

TAMPA, FL / ACCESSWIRE / April 12, 2022 / EV Biologics Corp, OTC PINK:YECO, today announced that it has succeeded in isolating primary progenitor cells from tissue using a xeno-free process. The Compa...

10 months ago - Accesswire

EV Biologics Updates on FINRA Filings

NASHVILLE, TN / ACCESSWIRE / March 9, 2022 / EV Biologics Corp, OTC PINK:YECO, today updated shareholders with the latest information about its submitted FINRA applications for name change and NFT div...

11 months ago - Accesswire

EV Biologics Updates on FINRA

NASHVILLE, TN / ACCESSWIRE / January 18, 2022 / EV Biologics Corp, OTC PINK:YECO, today updated shareholders with further details about its submitted FINRA applications for name change and NFT dividen...

1 year ago - Accesswire

EV Biologics Updates on NFT Dividend

NASHVILLE, TN / ACCESSWIRE / November 12, 2021 / EV Biologics Corp, (OTC PINK:YECO), today updated shareholders with further details about its NFT dividend. The Company is still awaiting approval from...

1 year ago - Accesswire

EV Biologics Signs Listing Agreement With INX

NASHVILLE, TN / ACCESSWIRE / November 11, 2021 / EV Biologics Corp, ("the Company"), OTC PINK:YECO, today confirmed that it has signed an agreement to list its common stock on the INX Securities ATS, ...

1 year ago - Accesswire

EV Biologics Chief Medical Officer Publication on COVID-19 & Exosomes

NASHVILLE, TN / ACCESSWIRE / October 28, 2021 / EV Biologics Corp, OTC Pink:YECO, today updated shareholders about a recent publication authored by its Chief Medical Officer, Dr. Jason Sanders. This r...

1 year ago - Accesswire

EV Biologics Updates on NFT Minting

NASHVILLE, TN / ACCESSWIRE / September 28, 2021 / EV Biologics Corp, OTC PINK:YECO, today updated shareholders with further details about its NFT and minting progress. Our NFT team has been minting th...

1 year ago - Accesswire

EV Biologics Updates on NFT Warrant Dividend Distribution

NASHVILLE, TN / ACCESSWIRE / August 30, 2021 / EV Biologics Corp, (OTC Pink:YECO), today updated shareholders with further details about its NFT Warrant Dividend distribution. The Company is currently...

1 year ago - Accesswire

EV Biologics Briefs Shareholders on Market Cap Peer Comparison

NASHVILLE, TN / ACCESSWIRE / August 12, 2021 / EV Biologics Corp, OTC Pink:YECO, today briefed shareholders on its current value compared to other public biotechnology companies in its peer group. Ple...

1 year ago - Accesswire

EV Biologics NFT Dividend Information

NASHVILLE, TN / ACCESSWIRE / August 9, 2021 / EV Biologics Corp, OTC PINK:YECO, today updated shareholders with further details about its NFT Warrant Dividend. Attached is a preliminary image from the...

1 year ago - Accesswire

EV Biologics NFT Dividend Warrant Date

NASHVILLE, TN / ACCESSWIRE / July 30, 2021 / EV Biologics Corp., OTC PINK:YECO, today confirmed for share holders its NFT Warrant Dividend shareholders-of-record date. YECO's shareholders-of-record on...

1 year ago - Accesswire

EV Biologics Starts Custom Cell Isolation with Lonza Cell Bio Services

NASHVILLE, TN / ACCESSWIRE / July 28, 2021 / EV Biologics Corp, OTC PINK:YECO today announced that it has signed an agreement with Lonza Cell Bio Services to implement a custom cell isolation in prepa...

1 year ago - Accesswire

EV Biologics Unveils NFT Dividend Warrant

NASHVILLE, TN / ACCESSWIRE / July 26, 2021 / EV Biologics Corp, OTC PINK:YECO, today updated shareholders about its NFT dividend Warrant. The Company will distribute one (1) Warrant for every 100 shar...

1 year ago - Accesswire

EV Biologics Signs LOI with Lonza Cell & Gene Therapy

NASHVILLE, TN / ACCESSWIRE / July 22, 2021 / EV Biologics Corp., (OTC PINK:YECO) today announced that it has signed a Letter of Intent (LOI) with Lonza Cell & Gene Therapy for Process Development and ...

1 year ago - Accesswire

EV Biologics NFT Dividend Update

NASHVILLE, TN / ACCESSWIRE / July 19, 2021 / EV Biologics Corp, OTC PINK:YECO, today updated shareholders about its NFT dividend. On July 14, 2021 the Company announced a dividend of 1 NFT for every 1...

1 year ago - Accesswire

EV Biologics Announces NFT Dividend

CHEYENNE, WY / ACCESSWIRE / July 14, 2021 / EV Biologics Corp, OTC PINK:YECO, today announced that it will distribute a dividend of one (1) Non-Fungible Token (NFT) for every 100 shares of YECO common...

1 year ago - Accesswire

EV Biologics is now Pink Current

CHEYENNE, WY / ACCESSWIRE / June 14, 2021 / EV Biologics Corp (OTC PINK:YECO) today announced that it has completed all its filings on OTC Markets and is now Pink Current. Being current and Penny Stoc...

1 year ago - Accesswire

EV Biologics Updates Shareholders on Name and Symbol Change

CHEYENNE, WY / ACCESSWIRE / May 19, 2021 / EV Biologics Corp., OTC PINK:YECO, is taking this opportunity to update our shareholders and other investors concerning the status of our name change submiss...

1 year ago - Accesswire

EV Biologics Confirms Funding to Commence Cell Line Generation & Advance Exosome Research

NASHVILLE, TN / ACCESSWIRE / April 8, 2021 / EV Biologics Corp (OTC PINK:YECO) today announced that it has signed a director's loan agreement to secure funding of up to $5 million to start generation ...

1 year ago - Accesswire